Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer
Laufey T. Ámundadóttir(National Institutes of Health), Dominique S. Michaud(National Cancer Institute), Robert R. McWilliams(Mayo Clinic in Arizona), Susan E. Hankinson(University of Massachusetts Amherst), J. Michael Gaziano(VA Boston Healthcare System), Steven Gallinger(Ontario Institute for Cancer Research), Alan A. Arslan(New York University), Demetrius Albanes(National Cancer Institute), Alison P. Klein(Johns Hopkins University), Rudolf Kaaks(German Cancer Research Center), Françoise Clavel‐Chapelon(Inserm), William R. Bamlet(Mayo Clinic), Edward L. Giovannucci(Massachusetts Department of Public Health), Mariza de Andrade(Mayo Clinic), Franco Berrino(Tumori Foundation), Mazda Jenab(Centre international de recherche sur le cancer), Gloria M. Petersen(Mayo Clinic), Charles S. Fuchs(University of Southern California), Paige M. Bracci(University of California, San Francisco), Eric J. Jacobs(American Cancer Society), Peter Kraft(National Cancer Institute), Sandra Clipp(Johns Hopkins University), Michelle Cotterchio(University of Toronto), Eric J. Duell(Dartmouth College), Rachael Z. Stolzenberg‐Solomon(National Cancer Institute), Andrea Z. LaCroix(Human Longevity (United States)), Shannon M. Lynch(Fox Chase Cancer Center), Myron Gross(University of Minnesota), David J. Hunter(The University of Sydney), Margaret T. Mandelson(Group Health Cooperative), Kevin B. Jacobs(Emergent BioSolutions (United States)), Julie B. Mendelsohn(National Institutes of Health), Amy Hutchinson(National Institutes of Health), Robert C. Kurtz(Memorial Sloan Kettering Cancer Center), Michael Goggins(Johns Hopkins University), Julie E. Buring(Brigham and Women's Hospital), Donghui Li(The University of Texas MD Anderson Cancer Center), Wei Zheng(Vanderbilt University), Christine D. Berg(National Cancer Institute), Carlos A. González(Bellvitge University Hospital), John W. Fox(Michigan State University), Göran Hallmans(Umeå University), Rebecca D. Jackson(The Ohio State University), Sheila Bingham(Medical Research Council), Kathy J. Helzlsouer(Mercy Medical Center), H. Bas Bueno‐de‐Mesquita(University Medical Center Utrecht), Elizabeth A. Holly(University of California, San Francisco), Charles Kooperberg(Fred Hutch Cancer Center), Manal M. Hassan(The University of Texas MD Anderson Cancer Center), Federico Canzian(German Cancer Research Center)
Cited by 724
Related Papers
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
|Journal of Clinical Oncology|2007|3.9k
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
|New England Journal of Medicine|2002|3.6k